GLORY PHARMACEUTICALS (Glory), is a biopharmaceutical company focused on the development and commercialization of products to prevent and treat cancer. The company's technology is based upon the discovery of a biological compound, which has demonstrated the ability to induce "selectiveapoptosis", or programmed cancer cell death, in both pre-cancerous and cancerous cells, while exhibiting little damage to normal cells. Glory's first product candidate, CHML, has been evaluated by a number of respected laboratories, using in-vitro cellular experiments and animal models. Additionally, CHML has been used to treat over 400 patients in several countries outside of the U.S., (stage II - IV), diagnosed with a broad range of solid tumors and blood borne malignancies. Glory's proprietary, biological medicine (CHML) may have the potential to re-shape the palliative based treatment goals of today's oncologist, in a broad range of life-threatening malignant disorders.
| Website | http://www.glorypharma.com |
| Revenue | $9 million |
| Employees | View employees |
| Address | 2771 Manhattan Pl, Vienna, Virginia 22180, US |
| Phone | +1 703-204-1703 |
| Fax | (703) 204-1704 |
| Industry | Manufacturing General, Manufacturing |
| Competitors | Thermo Fisher Scientific, BD, Merck Group, Agilent Technologies, PerkinElmer, Inc., Waters Corporation, Bio-Rad Laboratories, QIAGEN, Eppendorf Group, Genomatix AG +40 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 32 Companies |
Looking for a particular Glory F&D employee's phone or email?
Glory F&D Questions
The Glory F&D annual revenue was $9 million in 2026.
Glory F&D is based in Vienna, Virginia.
The NAICS codes for Glory F&D are [325, 32541, 3254, 32].
The SIC codes for Glory F&D are [283, 28].
